Results 161 to 170 of about 60,513 (321)
PROGNOSTIC CLASSIFICATION OF MYELOFIBROSIS WITH MYELOID METAPLASIA [PDF]
, 1989 Giovanni Barosi
openalex +1 more source
Expert Perspective: Hematologic Malignancies and Vasculitis
Arthritis &Rheumatology, Volume 77, Issue 10, Page 1305-1316, October 2025.
Michelle L. Robinette, Hetty E. Carraway
wiley +1 more source
Contraception in Myeloproliferative Neoplasms: A Pharmacological Review
European Journal of Haematology, Volume 115, Issue 4, Page 344-348, October 2025.ABSTRACT Myeloproliferative neoplasms (MPNs) are chronic hematologic disorders characterized by clonal proliferation of myeloid lineage cells, commonly driven by JAK2 mutations, and associated with significant thrombotic and hemorrhagic complications.
Awni Alshurafa +4 more
wiley +1 more source
Acute myelofibrosis: Report of a case and review of current literature [PDF]
, 1989 Gregory G Marino
openalex +1 more source
International Journal of Laboratory Hematology, Volume 47, Issue 5, Page 869-876, October 2025.ABSTRACT Introduction The majority of patients with essential thrombocythemia (ET) show somatic mutations of JAK2, CALR, or MPL. Around 10% of cases lack these mutations (“triple negative” ET, TN‐ET). Additionally, some patients with bona fide “primary thrombocytosis” (PT) [i.e., high platelet (PLT)‐ count with no apparent underlying causes] do not ...
Valentina Sangiorgio +8 more
wiley +1 more source
The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis [PDF]
, 1985 Jonathan Miller +3 more
openalex +1 more source
Neurological manifestations of chronic graft versus host disease
Internal Medicine Journal, Volume 55, Issue 10, Page 1639-1646, October 2025.Abstract Introduction Allogeneic haemopoietic stem cell transplant (allo‐HSCT) is an established therapy for many malignant and non‐malignant conditions, with an increasing number of uses and indications in recent decades. Complications including graft versus host disease (GvHD) carry significant morbidity and mortality.
Tal Koren +7 more
wiley +1 more source
Immunologic abnormalities in myelofibrosis with activation of the complement system [PDF]
, 1981 BR Gordon, M Coleman, P Kohen, N K Day
openalex +1 more source
Сучасні класифікації хронічних мієлопроліферативних захворювань: стандарти та тенденції вдосконалення [PDF]
, 2008 In work modern signs on classification of chronic myeloproliferative diseases are presented. The role oncogene in pathogenesis myeloproliferative diseases, their basic influence on development of pathology is covered.
Лисенко, Д.А.
core